[A long survival after the treatment of a squamous cell carcinoma of the gallbladder]

M Bourmèche; H Ben Salah; M Kallel; M I Beyrouti; S Makni; T Boudawara; M Frikha; J Daoud

doi:10.1016/j.canrad.2012.12.005

[A long survival after the treatment of a squamous cell carcinoma of the gallbladder]

Cancer Radiother. 2013 Feb;17(1):58-61. doi: 10.1016/j.canrad.2012.12.005. Epub 2013 Jan 24.

[Article in French]

Authors

M Bourmèche¹, H Ben Salah, M Kallel, M I Beyrouti, S Makni, T Boudawara, M Frikha, J Daoud

Affiliation

¹ Service de radiothérapie, faculté de médecine, université de Sfax, CHU Habib-Bourguiba, route Majida-Boulila, 3029 Sfax, Tunisie.

PMID: 23352563
DOI: 10.1016/j.canrad.2012.12.005

Abstract

We report the case of a long survival after the treatment of a squamous cell carcinoma of the gallbladder. The patient is a 58-year-old man, who was treated by cholecystectomy, followed by postoperative radiotherapy of the tumour bed at a dose of 45Gy, combined with 5-fluoro-uracil chemotherapy. After 18 years, the patient is alive in complete remission. The end point of this work was to study the clinical and therapeutic characteristics of squamous cell carcinoma of the gallbladder and its prognosis through this case and a review of literature.

Publication types

Case Reports
Review

MeSH terms

Antimetabolites, Antineoplastic / therapeutic use*
Carcinoma, Squamous Cell / complications
Carcinoma, Squamous Cell / surgery
Carcinoma, Squamous Cell / therapy*
Chemoradiotherapy, Adjuvant*
Cholecystectomy*
Cholelithiasis / complications
Cholelithiasis / diagnostic imaging
Cholelithiasis / surgery
Combined Modality Therapy
Disease Management
Fluorouracil / therapeutic use*
Gallbladder Neoplasms / complications
Gallbladder Neoplasms / surgery
Gallbladder Neoplasms / therapy*
Humans
Male
Middle Aged
Prognosis
Radiotherapy Dosage
Radiotherapy, Conformal*
Remission Induction
Survivors*
Ultrasonography

Substances

Antimetabolites, Antineoplastic
Fluorouracil